“These results illustrate that cannabis regulation, coupled with consumer education, can provide sufficient safeguards to protect — and potentially even improve — mental health outcomes, particularly among more vulnerable populations.” The post Study: Cannabis Legalization Associated With Fewer Hospitalizations Among Schizophrenia Patients appeared first on NORML.
Author: Extroverting
Judge gives initial OK to $8M Aurora Cannabis class-action settlement
A federal judge granted preliminary approval to an $8.05 million settlement between Aurora Cannabis Inc. (NASDAQ: ACB) and investors who accused the company of misleading them through an boomerang deal to inflate its revenue, Law360 reported. U.S. Magistrate Judge James B. Clark III gave the initial nod to the proposed …
Bright Minds stock jumps over 3,000% in five days
Psychedelic drug company Bright Minds Biosciences Inc. (NASDAQ: DRUG) saw its stock rocket higher by 1,445% to close the day on Tuesday at $38.49 as the stock rose $36 per share. The stock had opened at $2.67 per share and has mostly traded in the range of $1-$2 over the …
Tsunami of debt heading toward the biggest cannabis companies
There is a tsunami of debt headed straight for the cannabis industry. When capital dried up a few years ago, many publicly traded cannabis companies turned to debt for needed funding. Now, roughly $1.83 billion of that debt is set to come due by 2026. Facing the wave There’s no …